Hematology

Hematology is the study of blood and its diseases. Some of these conditions are malignant (cancerous), while others are benign (noncancerous). Even benign blood disorders can cause serious complications without the right care. 

Specialists called hematologists “blood doctors” lead a team of experts to provide the care you need. At the Penn Blood Disorders Center, we bring together a specialized group focused on benign blood disorders. We also work closely with the Abramson Cancer Center at Penn Medicine to treat some conditions, such as blood cancers (hematological malignancies). 

People travel to see us from across the Mid-Atlantic and beyond. While we offer the top care they seek, they tell us they also appreciate the environment we’ve created. We know blood disorders can feel challenging at times, so we’ve created a place where you can feel comfortable and supported. 

• Welcoming expertise: Our doctors are leaders in the field of blood disorders. They publish influential papers, give talks worldwide, and serve in professional groups, such as the American Society of Hematology. They know, though, that the best care goes beyond expertise. They want your experience to feel comfortable, like a visit to your local doctor’s office.
• Thorough care: We have one of the largest, most complete hematology groups in the region. In addition to hematologists, our team includes nurses and other advanced practice providers, physical therapists, social workers, and a psychologist specializing in pain. A nurse coordinator serves as your main contact. We also partner with a range of other top Penn Medicine specialists. 
• Flexibility: You can choose to get all your care at our center, seek a second opinion, or travel to us only for major checkups. We work with your local doctors to ensure you can receive day-to-day care closer to home if preferred. 
• Innovation: We’re working to answer big questions about blood disorders and improve care. In addition to leading research, we participate in clinical trials to develop new treatments, including gene therapy.